What medical evaluations has Joe Biden undergone recently and what were the results?
This fact-check may be outdated. Consider refreshing it to get the most current information.
Executive summary
Former President Joe Biden underwent a routine physical in mid‑May 2025 that identified a small prostate nodule requiring “further evaluation,” and in May 2025 his office later disclosed a diagnosis of metastatic prostate cancer being treated with hormone therapy and radiation; reports describe the cancer as aggressive but hormone‑sensitive [1] [2] [3]. Public records and past summaries show he had a multi‑specialty medical evaluation while in office that listed chronic conditions including atrial fibrillation, sleep disorder and elevated lipids [4].
1. What was found in the most recent check‑up: a prostate nodule and follow‑up
In May 2025 Biden’s team confirmed that a routine physical revealed a “small nodule” on his prostate, prompting further tests; outlets including ABC, Newsweek and local reporting noted the office statement that evaluation was needed, without immediate detail on biopsy timing or PSA values [1] [5] [6]. Those reports emphasized that a prostate nodule is not automatically cancerous and that further workup is the standard next step [1].
2. The subsequent public announcement: metastatic prostate cancer and treatment
Mainstream outlets reported that Biden’s team later disclosed a diagnosis of metastatic prostate cancer and that he began treatment that included hormone therapy and a course of radiation; medical experts quoted in coverage characterized the cancer as hormone‑sensitive, meaning it can often be managed with these therapies [2] [3]. Reuters and The New York Times framed the diagnosis in the context of broader scrutiny of Biden’s health during and after his presidency [2] [7].
3. Historical medical context supplied by earlier evaluations
A detailed public summary from a multi‑specialty team at the Bethesda military medical facility (published February 2024) listed existing conditions for which Biden received treatment: sleep disorder, atrial fibrillation (a heart rhythm disorder), abnormal lipid levels, gastroesophageal reflux, peripheral nerve pain in his legs, and seasonal allergies; that report was cited by medical reporters analyzing his care [4]. Earlier presidential physicals had prompted the “fit to serve” designation in 2023, but public summaries did not include continuous PSA screening after 2014, according to reporting [4] [7].
4. Gaps in public information and limits of reporting
Available sources do not provide the full sequence of diagnostic tests (PSA level, imaging reports, biopsy details) or precise staging data beyond the designation “metastatic” in summarized reporting; outlets reported the diagnosis and treatment plan but did not publish the full medical records or lab results [2] [3]. The New York Times noted Biden aides said physicians stopped PSA testing after 2014, which could have limited earlier detection — that claim is reported but the underlying medical rationale is not fully disclosed in the items provided [7].
5. Competing narratives and political fallout in coverage
Coverage and political responses diverge: journalists and clinicians framed the news as a medical event with standard treatments, while critics and congressional investigators later raised questions about medical transparency and whether political advisers influenced testing and disclosure decisions during his presidency [3] [8]. An Oversight Committee report released in October 2025 accused aides of interfering with medical decision‑making and withholding cognitive testing; that report is a political finding whose allegations contrast with medical summaries published earlier [8].
6. What experts and prior reporting highlighted about surveillance and screening
Commentary from veteran medical reporters and specialists noted routine screening practices and questioned why some tests — notably PSA — were not performed after 2014, suggesting that absence of serial PSA data complicates retrospective assessment of when cancer became detectable; that line of inquiry is reported by The New York Times and specialist commentary [7] [4]. Medical analysts also emphasized that not all prostate nodules represent cancer and that hormone‑sensitive metastatic disease can often be controlled with current therapies [1] [3].
7. Bottom line for readers: what is established and what remains unanswered
Established by contemporary reporting: a prostate nodule was found at a routine exam in May 2025, Biden was later publicly diagnosed with metastatic prostate cancer, and he entered hormone therapy with a course of radiation described in later accounts [1] [2] [3]. Unresolved in available reporting: detailed lab values, full imaging and pathology reports, the exact timeline from nodule detection to diagnosis, and internal decision‑making about the cadence of PSA screening while he was in office [7] [2].
Limitations: this summary relies only on the cited public reports; full clinical records and private physician notes are not part of the sources provided here [1] [2].